H. Laurance Fuller is Director at ABBOTT LABORATORIES (ABT). They have made 9 open-market trades across 3 companies since 2006, most recently 2016-03-03.
CIK 0001187553
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $52K since 2006, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CCMP | SELL | 2013-12-06 | 2013-12-09 | $44.02 | $639K | -9.5% | +0.6% | +0.6% |
| ABT | SELL | 2012-03-19 | 2012-03-21 | $60.30 | $1.2M | -8.3% | -2.3% | -2.3% |
| CCMP | SELL | 2012-02-17 | 2012-02-17 | $50.46 | $2.1M | -9.5% | +0.6% | +0.6% |
| ABT | SELL · 10b5-1 | 2011-02-14 | 2011-02-16 | $46.00 | $284K | -8.3% | -2.3% | -2.3% |
| ABT | SELL | 2010-02-02 | 2010-02-04 | $54.40 | $309K | -8.3% | -2.3% | -2.3% |
| ABT | SELL | 2009-02-18 | 2009-02-20 | $53.85 | $211K | -8.3% | -2.3% | -2.3% |
| ABT | SELL · 10b5-1 | 2008-04-23 | 2008-04-25 | $50.59 | $259K | -8.3% | -2.3% | -2.3% |
| ABT | SELL | 2007-01-30 | 2007-02-01 | $53.08 | $376K | -8.3% | -2.3% | -2.3% |
| MOT | BUY | 2006-08-31 | 2006-10-02 | $23.53 | $52K | N/A | N/A | N/A |
| ABT | SELL | 2006-05-09 | 2006-05-11 | $42.30 | $134K | -8.3% | -2.3% | -2.3% |
| MOT | SELL | 2006-05-03 | 2006-05-04 | $21.92 | $73K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.